| Past two years | Past Year | Past 30 Days | |
|---|---|---|---|
| Abstract Views | 973 | 704 | 44 |
| Full Text Views | 14 | 1 | 0 |
| PDF Downloads | 10 | 2 | 0 |
Immunotherapy for Porcine Cysticercosis: Implications for Prevention of Human Disease
Carlton A. W. Evans
Carlton A. W. Evans
Department of Medicine, Addenbrooke's Hospital, Universidad Nacional Mayor de San Marcos, Asociacion Benefica Proyectos en Informatica, Salud, Medicina y Agricultura (PRISMA), Johns Hopkins School of Public Health and Hygiene, Universidad Peruana Cayetano Heredia, Division of Parasitic Diseases, Centers for Disease Control and Prevention, Cambridge, United Kingdom
Search for other papers by Carlton A. W. Evans in
Current site
Google Scholar
PubMed
Search for other papers by Carlton A. W. Evans in
Current site
Google Scholar
PubMed
Armando E. Gonzalez
Armando E. Gonzalez
Department of Medicine, Addenbrooke's Hospital, Universidad Nacional Mayor de San Marcos, Asociacion Benefica Proyectos en Informatica, Salud, Medicina y Agricultura (PRISMA), Johns Hopkins School of Public Health and Hygiene, Universidad Peruana Cayetano Heredia, Division of Parasitic Diseases, Centers for Disease Control and Prevention, Cambridge, United Kingdom
Search for other papers by Armando E. Gonzalez in
Current site
Google Scholar
PubMed
Search for other papers by Armando E. Gonzalez in
Current site
Google Scholar
PubMed
Robert H. Gilman
Robert H. Gilman
Department of Medicine, Addenbrooke's Hospital, Universidad Nacional Mayor de San Marcos, Asociacion Benefica Proyectos en Informatica, Salud, Medicina y Agricultura (PRISMA), Johns Hopkins School of Public Health and Hygiene, Universidad Peruana Cayetano Heredia, Division of Parasitic Diseases, Centers for Disease Control and Prevention, Cambridge, United Kingdom
Search for other papers by Robert H. Gilman in
Current site
Google Scholar
PubMed
Search for other papers by Robert H. Gilman in
Current site
Google Scholar
PubMed
Manuela Verastegui
Manuela Verastegui
Department of Medicine, Addenbrooke's Hospital, Universidad Nacional Mayor de San Marcos, Asociacion Benefica Proyectos en Informatica, Salud, Medicina y Agricultura (PRISMA), Johns Hopkins School of Public Health and Hygiene, Universidad Peruana Cayetano Heredia, Division of Parasitic Diseases, Centers for Disease Control and Prevention, Cambridge, United Kingdom
Search for other papers by Manuela Verastegui in
Current site
Google Scholar
PubMed
Search for other papers by Manuela Verastegui in
Current site
Google Scholar
PubMed
Hector H. Garcia
Hector H. Garcia
Department of Medicine, Addenbrooke's Hospital, Universidad Nacional Mayor de San Marcos, Asociacion Benefica Proyectos en Informatica, Salud, Medicina y Agricultura (PRISMA), Johns Hopkins School of Public Health and Hygiene, Universidad Peruana Cayetano Heredia, Division of Parasitic Diseases, Centers for Disease Control and Prevention, Cambridge, United Kingdom
Search for other papers by Hector H. Garcia in
Current site
Google Scholar
PubMed
Search for other papers by Hector H. Garcia in
Current site
Google Scholar
PubMed
Alfonso Chavera
Alfonso Chavera
Department of Medicine, Addenbrooke's Hospital, Universidad Nacional Mayor de San Marcos, Asociacion Benefica Proyectos en Informatica, Salud, Medicina y Agricultura (PRISMA), Johns Hopkins School of Public Health and Hygiene, Universidad Peruana Cayetano Heredia, Division of Parasitic Diseases, Centers for Disease Control and Prevention, Cambridge, United Kingdom
Search for other papers by Alfonso Chavera in
Current site
Google Scholar
PubMed
Search for other papers by Alfonso Chavera in
Current site
Google Scholar
PubMed
Joy B. Pilcher
Joy B. Pilcher
Department of Medicine, Addenbrooke's Hospital, Universidad Nacional Mayor de San Marcos, Asociacion Benefica Proyectos en Informatica, Salud, Medicina y Agricultura (PRISMA), Johns Hopkins School of Public Health and Hygiene, Universidad Peruana Cayetano Heredia, Division of Parasitic Diseases, Centers for Disease Control and Prevention, Cambridge, United Kingdom
Search for other papers by Joy B. Pilcher in
Current site
Google Scholar
PubMed
Search for other papers by Joy B. Pilcher in
Current site
Google Scholar
PubMed
Victor C. W. Tsang
Victor C. W. Tsang
Department of Medicine, Addenbrooke's Hospital, Universidad Nacional Mayor de San Marcos, Asociacion Benefica Proyectos en Informatica, Salud, Medicina y Agricultura (PRISMA), Johns Hopkins School of Public Health and Hygiene, Universidad Peruana Cayetano Heredia, Division of Parasitic Diseases, Centers for Disease Control and Prevention, Cambridge, United Kingdom
Search for other papers by Victor C. W. Tsang in
Current site
Google Scholar
PubMed
Search for other papers by Victor C. W. Tsang in
Current site
Google Scholar
PubMed
The Cysticercosis Working Group in Peru*
The Cysticercosis Working Group in Peru*
Department of Medicine, Addenbrooke's Hospital, Universidad Nacional Mayor de San Marcos, Asociacion Benefica Proyectos en Informatica, Salud, Medicina y Agricultura (PRISMA), Johns Hopkins School of Public Health and Hygiene, Universidad Peruana Cayetano Heredia, Division of Parasitic Diseases, Centers for Disease Control and Prevention, Cambridge, United Kingdom
Search for other papers by The Cysticercosis Working Group in Peru* in
Current site
Google Scholar
PubMed
Search for other papers by The Cysticercosis Working Group in Peru* in
Current site
Google Scholar
PubMed
Taenia solium cysticercosis is an important cause of human disease in many developing countries. Porcine cysticercosis is a vital link in the transmission of this disease and impairs meat production. A treatment for porcine cysticercosis may be an effective way of preventing human disease that would also benefit pig farmers, facilitating control programs in disease-endemic regions. Previous research suggests that reinfection with cysticercosis or immunotherapy with cysticercal antigens may cause degeneration of cysticerci, potentially curing porcine cysticercosis. Therefore, a blinded, randomized, controlled study to assess the efficacy and safety of immunotherapy in 28 naturally parasitized pigs was performed. Four groups of pigs with similar weights were inoculated twice with membrane-enriched cysticercal antigens (MA), saline, aqueous-soluble crude cysticercal antigens (AA) in adjuvant (Freund's complete then incomplete), or adjuvant alone. Immunotherapy was well tolerated but had no consistent effect on the macroscopic appearance of cysticerci or eosinophil count. Histopathologic findings were variable, with both severe and minimal inflammatory reactions seen in adjacent cysticerci in all pigs. Nine (64%) of 14 pigs given immunotherapy developed new antibody bands on electroimmunotransfer blot compared with one (7%) of 14 control pigs (P < 0.01). Treatment with AA in adjuvant caused a significant increase in the proportion of cysticerci that failed to evaginate and were, therefore, not viable for infecting humans (34% for pigs given AA in adjuvant compared with 10% for adjuvant alone; P < 0.04). Although immunotherapy caused a statistically significant decrease in the viability of cysticerci, this immunologic reaction was not great enough to prevent human disease.
Author Notes
Other members of the Cysticercosis Working Group in Peru are Maritza Alvarez, Cesar Carcamo, Miguel Castro, Fernando Diaz, Genaro Herrera, Olga Li, Manuel Martinez, Elba Miranda, Teresa Montenegro, Jorge Naranjo, and Patricia Torres.
| Past two years | Past Year | Past 30 Days | |
|---|---|---|---|
| Abstract Views | 973 | 704 | 44 |
| Full Text Views | 14 | 1 | 0 |
| PDF Downloads | 10 | 2 | 0 |